Up a level |
Waters, Laura, Winston, Alan, Reeves, Iain, Boffito, Marta, Churchill, Duncan, Cromarty, Ben, Dunn, David, Fink, Douglas, Fidler, Sarah, Foster, Caroline et al (show 14 more authors)
(2022)
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
HIV MEDICINE, 23 (S5).
pp. 3-115.
Churchill, Duncan, Waters, Laura, Ahmed, Nadia, Angus, Brian, Boffito, Marta, Bower, Mark, Dunn, David, Edwards, Simon, Emerson, Carol, Fidler, Sarah et al (show 21 more authors)
(2016)
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
HIV MEDICINE, 17 (S4).
S2-S104.
Stohr, Wolfgang, Dunn, David T, Arenas-Pinto, Alejandro, Orkin, Chloe, Clarke, Amanda, Williams, Ian, Johnson, Margaret, Beeching, Nicholas J ORCID: 0000-0002-7019-8791, Wilkins, Edmund, Sanders, Karen et al (show 1 more authors)
(2016)
Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy.
AIDS, 30 (17).
pp. 2617-2624.
Geretti, Anna Maria ORCID: 0000-0002-3670-6588, White, Ellen, Orkin, Chloe, Tostevin, Anna, Tilston, Peter, Chadwick, David, Leen, Clifford, Sabin, Caroline, Dunn, David T and UK HIV Drug Resistance Database and UK CHIC Study,
(2018)
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.
The Journal of antimicrobial chemotherapy, 74 (3).
pp. 746-753.
Iwuji, Collins C, Churchill, Duncan, Bremner, Stephen, Perry, Nicky, To, Ye, Lambert, Debbie, Bruce, Chloe, Waters, Laura, Orkin, Chloe and Geretti, Anna Maria ORCID: 0000-0002-3670-6588
(2020)
A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial.
BMC infectious diseases, 20 (1).
p. 524.